Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

BIO’s Livestock Biotech Summit Becomes Animal Biotech Summit to Reflect New Theme and Goals

“Advancing One Health through Biotechnology”

BIO Comments on FDA Natural Food Labeling

The Biotechnology Innovation Organization (BIO) is pleased to submit these comments to FDA in response to FDA’s request for information on the use of the term “natural” on food labeling (docket no. FDA-2014-N-1207). BIO is the world's largest biotechnology trade association, representing companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than thirty other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.

BIO Submits Comments Re: Medicare Program; Part B Drug Payment Model [CMS-1670-P]

The Biotechnology Innovation Organization appreciates this opportunity to submit comments on the Centers for Medicare and Medicaid Services’ proposed rule entitled Medicare Program; Part B Drug Payment Model...

Follow-Up on BIO’s Comments in Response to the ICER Value Framework

BIO Applauds Senators Heitkamp, Heller and Peters for Introducing the SEC Small Business Advocate Act

Bill would enhance the voice of emerging companies at the SEC

BIO Collaborates with NIH and NSF on Growing “Innovation Zone” at BIO 2016 International Convention

The Biotechnology Innovation Organization (BIO), the National Science Foundation (NSF) and the National Institutes of Health (NIH) today announced an agreement to feature Small Business Innovation Research (SBIR)-funded early-stage biomedical companies in an expanded Innovation Zone at the 2016 BIO International Convention. 

BIO Statement on USTR’s 2016 “Special 301 Report”

The Biotechnology Innovation Organization (BIO) released the following statement regarding The Office of the United States Trade Representative’s (USTR) 2016 Special 301 Report:

CSRxP Plan Fails to Tackle Real Drivers of Consumer Out of Pocket Costs

The Biotechnology Innovation Organization (BIO) issued the following statement today regarding the Campaign for Sustainable Rx Pricing’s policy proposals on prescription drug prices:

The 2016 BIO World Congress on Industrial Biotechnology Closed with a Record Number of Partnering Meetings

This year’s Conference drew around 907 industry leaders from 529 companies, 32 countries and 31 states, as well as the District of Columbia. Organized by the Biotechnology Innovation Organization (BIO), the World Congress on Industrial Biotechnology hosted more than 1,961 partnering meetings, nearly a 40% increase from the 2015 BIO World Congress.

BIO Presents Dr. Ganesh Kishore New Award for Leadership and Legacy in Industrial Biotechnology

BIO presented Dr. Ganesh Kishore, CEO, MLSCFI and co-Managing Partner, Spruce Capital Partners, the first annual BIO Leadership and Legacy Award today during BIO’s 13th Annual World Congress on Industrial Biotechnology. The new award was created to honor an individual who has shown exemplary leadership and who has dedicated a significant portion of their career to advancing industrial biotechnology and growing the biobased economy.